Published in Pharma Law Weekly, December 6th, 2005
According to recent research from Australia, "Numeric grading systems have been validated for the reporting of mammographic abnormalities and for breast cytology. The impact of integrating lesion grades from both disciplines on the accuracy of assessment of screen-detected lesions has not been investigated."
G. Farshid and colleagues wrote, "In the current study, all lesions were prospectively classified using the Tabar radiologic grading system, as well as the National Health Service Breast Screening Program (NHSBSP) cytologic reporting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly